The arrival of Retatrutide ZPHC, at a strength of 120mg, is generating considerable excitement within the healthcare community. This novel dual GIP and GLP-1 receptor medication seems to offer notable improvements in fat reduction compared to current therapies. Early patient studies have demonstrated marked decreases in body mass , potentially r… Read More